MPO and Parkinson disease: However, only HTHQ at a dose of 50 mg/kg reduced serum MPO activity (p < 0.05) and was more effective in relation to MPO activity in the brains of rats with PD than HTHQ at a dose of 25 mg/kg (p < 0.05) and rasagiline (p < 0.05).